Oncolys BioPharma Inc. Logo

Oncolys BioPharma Inc.

Develops oncolytic virus therapies and diagnostics for cancer treatment.

4588 | T

Overview

Corporate Details

ISIN(s):
JP3202170001
LEI:
Country:
Japan
Address:
港区虎ノ門4−1−28虎ノ門タワーズオフィス10階

Description

Oncolys BioPharma Inc. is a biopharmaceutical company focused on the research and development of breakthrough therapies and diagnostics for cancer. The company's core technology is oncolytic virotherapy, which utilizes viruses to selectively target and destroy cancer cells. Its development pipeline addresses multiple stages of cancer care, spanning from early detection and prognostic testing to loco-regional and systemic treatments. The company aims to develop innovative and effective drugs to meet the needs of patients and healthcare providers in the field of oncology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 07:32
確認書
Japanese 8.7 KB
2025-08-08 07:31
半期報告書-第22期(2025/01/01-2025/12/31)
Japanese 271.3 KB
2025-07-18 08:30
有価証券届出書(参照方式)
Japanese 877.6 KB
2025-03-31 03:16
臨時報告書
Japanese 27.7 KB
2025-03-28 02:16
内部統制報告書-第21期(2024/01/01-2024/12/31)
Japanese 22.6 KB
2025-03-28 02:15
有価証券報告書-第21期(2024/01/01-2024/12/31)
Japanese 1.2 MB
2025-03-28 02:15
確認書
Japanese 8.7 KB
2024-08-09 08:07
確認書
Japanese 8.8 KB
2024-08-09 08:07
半期報告書-第21期(2024/01/01-2024/12/31)
Japanese 262.0 KB
2024-06-14 08:00
有価証券届出書(参照方式)
Japanese 785.1 KB
2024-05-10 08:08
確認書
Japanese 8.8 KB
2024-05-10 08:07
四半期報告書-第21期第1四半期(2024/01/01-2024/03/31)
Japanese 213.8 KB
2024-04-03 02:44
臨時報告書
Japanese 24.1 KB
2024-03-29 01:21
有価証券報告書-第20期(2023/01/01-2023/12/31)
Japanese 1.3 MB
2024-03-29 01:20
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all Oncolys BioPharma Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Oncolys BioPharma Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Oncolys BioPharma Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.